U.S. FDA panel recommends agency authorize Merck's COVID-19 drug
Summary
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left28Leaning Right8Center60Last Updated2 years agoBias Distribution63% Center
Bias Distribution
- 63% of the sources are Center
62% Center
L 29%
C 62%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage